You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small Cell Lung

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Nintedanib, gefitinib, erlotinib, afatinib
  • (no location specified)
Oct 2, 2023

Specific Protein Overexpression in Adult Non-Small Cell Lung

Not yet recruiting
  • Non Small Cell Lung Cancer
    • (no location specified)
    Sep 29, 2023

    Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

    Not yet recruiting
    • Stage II-IIIB(N2) Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 26, 2023

    Small Cell Lung Cancer Trial (Tarlatamab)

    Available
    • Small Cell Lung Cancer
    • (no location specified)
    Sep 26, 2023

    Small Cell Lung Cancer Trial in Cleveland (Alisertib)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Cleveland, Ohio
      Cleveland Clinic
    Oct 18, 2023

    NSCLC Trial in Shanghai

    Not yet recruiting
    • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 20, 2023

      Extensive Stage Small Cell Lung Cancer

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
        • Changsha, Hunan, China
          Hunan Cancer hospital
        Aug 6, 2023

        Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

        Not yet recruiting
        • Extensive Stage Small Cell Lung Cancer
        • hSTC810 400 mg + Paclitaxel
        • hSTC810 800 mg + Paclitaxel
        • (no location specified)
        Aug 24, 2023

        Molecular Analysis and Treatment Options of SCLC

        Recruiting
        • Small-cell Lung Cancer
        • +4 more
        • Shanghai, China
          Shanghai Chest Hospital
        Jul 6, 2023

        NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

        Recruiting
        • Non-small Cell Lung Cancer
        • +3 more
        • Yangzhou, Jiangsu, China
          People's hospital of northern jiangsu
        Sep 26, 2023

        Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

        Not yet recruiting
        • Relapsed Small Cell Lung Cancer
        • Irinotecan hydrochloride liposome Injection
        • Topotecan
        • Beijing, China
          Cancer Hospital, Chinese Academy of Medical Sciences
        Nov 7, 2023

        NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Tirelizumab；Chemotherapy monotherapy
        • (no location specified)
        Jul 27, 2023

        NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Iowa City, Iowa
          University of Iowa
        Oct 10, 2023

        Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

        Not yet recruiting
        • Small Cell Lung Cancer
        • Neuroendocrine Carcinoma
        • ZG006
        • Zhengzhou, Henan, China
          Henan Cancer Hospital
        Aug 6, 2023

        Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

        Recruiting
        • Small Cell Lung Cancer
        • Biospecimen Collection
        • Indianapolis, Indiana
        • +1 more
        Jun 2, 2023

        NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

        Not yet recruiting
        • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
        • (no location specified)
        Aug 27, 2023

        NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • (no location specified)
        Sep 6, 2023

        Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        Oct 4, 2023

        TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

        Not yet recruiting
        • Lung Cancer, Non-small Cell
        • Small Cell Lung Cancer
          • (no location specified)
          Nov 16, 2022

          Stage IB Non-small Cell Lung Cancer

          Completed
          • Stage IB Non-Small Cell Lung Carcinoma
            • Shanghai, China
              180 Fenglin Road
            Jul 29, 2023

            Identify Resected Non-small-cell Lung Cancer With High Risk of

            Recruiting
            • Non-small Cell Lung Cancer Stage IIIA
            • Resected non small cell lung cancer
            • Toulouse, France
              Julien MAZIERES
            Feb 8, 2023

            NSCLC Trial in Beijing

            Recruiting
            • NSCLC
              • Beijing, China
                Yuyan Wang
              Oct 10, 2023

              Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

              Recruiting
              • Non-small Cell Lung Cancer (NSCLC)
              • Jinan, Shandong, China
                Shandong Cancer Hospital and Institute
              Aug 8, 2023